If you have been diagnosed with cancer you probably have thought about joining a clinical trial. But if you’re like most patients, you have questions.
Selecting the right trial is not an easy process for those involved. It’s certainly not easy for the patient, who is trying to navigate the complicated decision-making process. It’s not easy for many doctors either.
The timing is ideal for renewed attention in our quest to eradicate cancer. Our knowledge of the genomics of cancer has dramatically grown over the past decade, resulting in new forms of targeted therapies.
This post by Dr. Mikkael Sekeres is in response to a National Cancer Institute-backed group’s recommendation to change the definition of cancer, published July 29, 2013 in The Journal of the American Medical Association. The group recommends eliminating the word from some common diagnoses in an effort to change the approach to cancer detection and treatment.